Uncategorized

Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors

NEW YORK – (March 26, 2025) – Rarecells, Inc., a pioneering company in liquid biopsy, is pleased to announce the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of experience in the pharmaceutical, contract research, post-acute care, and medical diagnostic sectors. […]

Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors Read More »

Press Release: Rarecells announces Appointment of New Director to the Board

NEW YORK, Sept. 6, 2022 /PRNewswire/ — Rarecells, Inc. today announced the appointment of Dr. Neil Gunn, a recognized leader and expert in the diagnostic space, as an independent Board Director. “We are delighted to welcome Neil as Board Director. With his broad understanding of diagnostics and the Liquid Biopsy space he is well-positioned to provide valuable perspectives

Press Release: Rarecells announces Appointment of New Director to the Board Read More »

Prof. Patrizia Paterlini-Brechot – Rarecells, Inc. – embarks on the search for the First Cell to beat cancer

We are delighted to join the prestigious The Oncology Think Tank, initiated by Prof. Azra Raza – Director of the MDS Center at Columbia University in New York, USA. We aim to provide patients with blood tests that diagnose cancer well before the moment medical imaging analyses are able to detect the tumor mass, making cancer

Prof. Patrizia Paterlini-Brechot – Rarecells, Inc. – embarks on the search for the First Cell to beat cancer Read More »

2nd Liquid Biopsies Congress – Global Exchange

Attend the Keynote presentation ”New non-invasive approaches for early diagnosis and follow up of invasive cancers” of Prof. Patrizia Paterlini-Bréchot, CSO of Rarecells Diagnostics, during the 2nd Liquid Biopsies Congress, which will be held virtually and free to attend upon registration. Save the date: Thursday 2020, 08th October at 4:20 pm. For more information and

2nd Liquid Biopsies Congress – Global Exchange Read More »

Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference

Attend the Keynote presentation ” Clinical Applications of Circulating Tumor Cells in Predictive Oncology ” of Prof. Patrizia Paterlini-Bréchot, CSO of Rarecells Diagnostics, during the Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference in Rotterdam. Save the date: Wednesday 2019, 30th October at 09:45 am. For more information visit: https://www.selectbiosciences.com/conferences/biographies.aspx?speaker=1472017&conf=EXLBPEU2019

Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference Read More »

Picture of Patrizia Paterlini-Bréchot next to the Iset blood filtration machine

Professor Patrizia Paterlini-Bréchot, is named European Inventor Award 2019 finalist

Rarecells Diagnostics, a leading company in the field of Liquid Biopsy, announces today that the European Patent Office (EPO) has nominated Professor Patrizia Paterlini-Bréchot, as one of the three finalists of the European Inventor Award 2019 – category “Research”- for developing ISET®, a new diagnostic blood test for cancer (www.isetbyrarecells.com). The highly-sensitive ISET® test detects circulating tumour cells which play

Professor Patrizia Paterlini-Bréchot, is named European Inventor Award 2019 finalist Read More »

You're one click away from your download !

Please enter the requested information below and click SEND

You're one click away from your download !

Please enter the requested information below and click SEND

You're one click away from your download !

Please enter the requested information below and click SEND